Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Testing rates and outcomes in <i>Clostridioides difficile</i> infection between REM (racially and ethnically minoritized) and non-REM patients.

Infection control and hospital epidemiology·2026
Same author

Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing.

Redox biology·2026
Same author

Pivotal trial design considerations for new and next generation cell and gene therapies.

Journal of biopharmaceutical statistics·2026
Same author

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same author

Two-Stage Double-Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region.

Statistics in medicine·2026
Same author

Trans-Phylum Single Cell Orthology Reveals Conserved Ovarian Cell States Between Sea Urchin and Human.

Genome biology and evolution·2026

相关实验视频

Updated: Jun 26, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

设计和样本大小的确定多剂量随机二期试验的剂量优化的剂量优化.

Peng Yang1,2, Daniel Li3, Ruitao Lin2

  • 1Department of Statistics, Rice University, Houston, Texas, USA.

Statistics in medicine
|May 15, 2024
PubMed
概括
此摘要是机器生成的。

项目Optimus将癌症药物剂量从最大耐受剂量 (MTD) 转移到最佳的风险-益处. MERIT试验设计为这些多剂量随机试验提供了样本大小计算方法,确保了患者的安全.

关键词:
该项目是Optimus项目.发现剂量发现剂量剂量优化剂量优化随机的临床试验随机的临床试验风险与利益的评估风险与利益的评估.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.6K

相关实验视频

Last Updated: Jun 26, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.6K

科学领域:

  • 临床试验设计 临床试验设计
  • 药理学 药理学是指药理学的学科.
  • 生物统计学 生物统计学

背景情况:

  • 美国食品和药物管理局 (FDA) 启动了"最佳项目",将癌症药物剂量选择从最大耐受剂量 (MTD) 过渡到优化风险效益权衡的剂量.
  • 目前的FDA指导建议进行随机的II期试验,比较多个剂量,以确定最大限度地提高患者益处并最大限度地降低风险的最佳剂量.

研究的目的:

  • 提出一种新的方法来确定多剂量随机试验中的样本大小,以优化剂量.
  • 引入MERIT (多剂量随机试验) 设计,用于在早期瘤学试验中选择最佳剂量的框架.

主要方法:

  • 一般化I型误差和功率的标准定义,以适应剂量优化目标.
  • 开发了一个决策规则和算法,用于计算多剂量随机试验中的最佳样本大小.
  • 引入了MERIT设计,包括用于剂量选择的毒性和疗效数据.

主要成果:

  • 模拟研究证实了MERIT设计的理想操作特性,以优化剂量.
  • 每个剂量臂的样本大小为20-40名参与者,通常提供足够的功率和可接受的I型错误率.
  • 通过优化剂量策略,MERIT设计促进了患者的安全,并最大限度地提高了治疗效益.

结论:

  • MERIT设计为剂量优化试验的样本大小确定提供了统计学上合理的方法.
  • 这种方法支持Project Optimus,允许识别具有有利风险效益概况的最佳剂量.
  • 实施MERIT设计的软件可用于帮助临床试验研究人员.